News About: Pharm. Industry
Korea Foods Industry Association to set up industrial complex in China
Korea Foods Industry Association said on March 25 that it signed a partnership agreement with the Foods Processing District Committee in Qindao city, China, to establish a KFIA industrial complex at a 200,000 pyung ar...
Pfizer declares victory campaign against erectile dysfunction
Pfizer Inc. said it launched a new victory campaign against erectile dysfunction (ED) to reinvigorate all males' sexual behavior in over 100 countries.
In the victory campaign declaration in Vienna, Austria, Pfizer...
Four flagship products comprise 50% sales revenue of Handok Pharm
Handok Pharm said that four leading products - Amaryl, Tritace, Munobal, and Festal - accounted for half of sales revenue of the company in 2003, in addition to Lasix (furosemide) showing steady annual growth ...
Individual tablet descriptions to register in 7 days before sale
Any individual tablets provisionally required to file it registration application for an appropriate description to the Pharmacy Information Foundation at least 7 days before its market release according to the agreem...
Process patent-related disputes seen intensifying
With Korean pharmaceutical firms vigorously aiming to launch the first generic versions of major original drugs whose patent is to be soon expired, a number of patent disputes among domestic pharmaceutical firms and f...
Hanmi Pharm vows to make inroads to European market
Hanmi Pharm has recently won market authorizations of its first generic antibiotic ceftazidime from the UK and Germany, following ceftriaxone and cefotaxime and vowed to push up with its plan to make quicker inroads t...
Boehringer Ingelheim Korea named 2003 top OTC marketing team
The OTC marketing team of Boehringer Ingelheim Korea was selected as the 2003 best marketing team from Boehringer Ingelheim Operation situated at Asia, Africa and Australia.
Based on the stringent criteria such as...
Green Cross Sang-A achieved 125% of sales growth in 2003.
Green Cross Sang-A reported their 2003 annual business performances by 104.4 billion won of net sales (125.5% up from the previous year), 7,343 million won of operating income, 6,150 million won of ordinary income an...
KPTA to complete construction of drug test laboratory.
Korea Pharmaceutical Trade Association announced that Korea Drug Test Laboratory would have an inaugural ceremony on March 31 after completing its construction.
KPTA called for many dignitaries to participate in...
Gelfos-M scoops domestic antacid market
Boryung Pharm's Gelfos-M, Korea's renowned antacid brand for the past 30 years, has regained its popularity with higher sales revenue thanks to official brand recognition and customers' higher awareness. Its sales rec...
